NCLEX-RN
NCLEX-RN
Unlock full lesson + practice questions
12 more sections with scenarios, priorities, and review drills.
Pulmonary Langerhans cell histiocytosis (PLCH) is characterized by clonal proliferation of Langerhans cells (specialized dendritic cells bearing CD1a and CD207/langerin markers) that infiltrate the small airways and interstitium.
For Pulmonary Langerhans Cell Histiocytosis, connect the assessment cue to the immediate risk before selecting an action for RN. Start with stability, ABCs, neurologic change, medication risk, infection risk, and scope of practice. Then decide whether the safest next step is assess, intervene, escalate, teach, or evaluate response.
A missed priority in Pulmonary Langerhans Cell Histiocytosis can delay recognition of deterioration or allow preventable harm to continue. Protect the client first by verifying abnormal cues, using ordered precautions, escalating unstable findings, and reassessing after intervention.
In a Pulmonary Langerhans Cell Histiocytosis item, explain the first cue you noticed, the complication it predicts, the nursing action within scope, and the finding that proves the response worked.
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
When two answers look reasonable, pick the option that closes the dangerous data gap or reduces immediate harm before routine teaching. This keeps Pulmonary Langerhans Cell Histiocytosis reasoning tied to client safety instead of recall-only studying.
Review this topic against the current pathway blueprint or test plan, facility policy, medication monographs, and current clinical practice guidance. NurseNest content is educational and should be reconciled with local protocols and provider orders.
Final rapid review before practice
Unlock the interactive lesson quiz with a plan that includes this NCLEX-RN pathway. You can still explore topic-filtered questions from the bank hubs below.
